Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03207802 · ClinicalTrials.gov registry record
Remotely Monitoring Patients With Chronic Conditions in Their Home
A clinical trial, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- 36
- Enrollment target
NCT03207802: Completed study, sponsored by Baxter Healthcare Corporation.
NCT03207802 is a clinical trial that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03207802 has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
Study will collect data from the home using the CoVa Monitoring System. Data will be captured and retrospectively analysis to determine if the data provided can alert clinician about a patient's declining health.
Primary Outcome
Correlation between data collection and potential heart failure event
Interventions
- DEVICE Discontinuation of using device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2017-06-21 |
| Est. Completion | 2017-12-20 |
What the finished NCT03207802 record still lists
NCT03207802 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Discontinuation of using device is the first listed.
NCT03207802 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03207802 about?
NCT03207802 is a clinical study titled "Remotely Monitoring Patients With Chronic Conditions in Their Home". Study will collect data from the home using the CoVa Monitoring System. Data will be captured and retrospectively analysis to determine if the data provided can alert clinician about a patient's declining health.
What is the current status of trial NCT03207802?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2017-06-21. Estimated completion is 2017-12-20.
What interventions are being tested in trial NCT03207802?
The interventions under investigation include: Discontinuation of using device (DEVICE).
Who is sponsoring clinical trial NCT03207802?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI